...
首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >Novel N-aryl nicotinamide derivatives: Taking stock on 3,6-diazabicyclo[3.1.1]heptanes as ligands for neuronal acetylcholine receptors
【24h】

Novel N-aryl nicotinamide derivatives: Taking stock on 3,6-diazabicyclo[3.1.1]heptanes as ligands for neuronal acetylcholine receptors

机译:新型N-芳基烟酰胺衍生物:服用3,6-二氮杂双环[3.1.1]庚烷作为神经元乙酰胆碱受体的配体

获取原文
获取原文并翻译 | 示例

摘要

We designed the synthesis of a small library of 3-substituted-3,6-diazabicyclo[3.1.1]heptanes whose affinity on neuronal nicotinic receptors (nAChRs) was evaluated. Among the synthesized compounds, the 5-(3,6-diazabicyclo[3.1.1]heptane-3-yl)-N-(2-fluorophenyl)nicotinamide 43 proved to be the most interesting compound with alpha(4)beta(2) Ki value of 10 pM and a very high alpha(7)/alpha(4)beta(2) selectivity. Furthermore, compounds 35, 39 and 43 elicited a selective partial agonist activity for alpha(4)beta(2) nAChR subtype.
机译:我们设计了三个替代-3,6-diazabicclo [3.1.1]庚烷文库的合成,其对神经元烟碱受体(NACHRS)的亲和力进行了亲和力。 在合成化合物中,5-(3,6-二氮杂双环[3.1.1]庚烷-3-基)-N-(2-氟苯基)烟酰胺43被证明是最有趣的α(4)β(2) )ki值10 pm和非常高的α(7)/α(4)β(2)选择性。 此外,化合物35,39和43引发了α(4)β(2)NACHR亚型的选择性部分激动剂活性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号